Banner

Chimeric Antigen Receptor T (CAR-T) Cells Market Report 2023 – By Target Antigen (CD19, CD22, Other Antigens), By Application (Acute Lymphoblastic Leukaemia, Diffuse Large B-Cell Lymphoma, Other Applications), By End User (Hospitals, Cancer Research Centres, Clinics) – Market Size, Trends, And Market Forecast 2023-2032

Starting Price : $5000.00 | Pages : 200 | Published : January 2023 | SKU CODE : | Delivery Time: 2-3 business days | Format :


The chimeric antigen receptor T (CAR-T) cells refers to genetically engineered cells that fight with cancer cells to treat the disease. The chimeric antigen receptor T (CAR-T) cell therapy is a form of treatment in which the patient's T cells, a particular type of immune system cell, are altered in a lab so they will target cancer cells. Blood from a patient is drawn to get T cells. Then, in the lab, T cells are given the gene for a unique receptor, chimeric antigen receptor T (CAR-T), that attaches to a particular protein on the patient's cancer cells and helps fight cancer.

The main target antigens of chimeric antigen receptor T (CAR-T) cells are CD19, CD22, and other antigens. The CD19 antigen refers to the use of CAR T cells for the immunotherapy-based treatment of B-cell acute lymphoblastic leukemia. The applications of chimeric antigen receptor T (CAR-T) cells include acute lymphoblastic leukemia, diffuse large B-cell lymphoma, and other applications that are used in hospitals, cancer research centers, and clinics.

The chimeric antigen receptor T (CAR-T) market research report is one of a series of new reports from The Business Research Company that provides chimeric antigen receptor T (CAR-T) market statistics, including chimeric antigen receptor T (CAR-T) industry global market size, regional shares, competitors with a chimeric antigen receptor T (CAR-T) market share, detailed chimeric antigen receptor T (CAR-T) market segments, market trends and opportunities, and any further data you may need to thrive in the chimeric antigen receptor T (CAR-T) industry. This chimeric antigen receptor T (CAR-T) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The global chimeric antigen receptor T (CAR-T) cells market size is expected to grow from $1.96 billion in 2022 to $2.76 billion in 2023 at a compound annual growth rate (CAGR) of 40.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The chimeric antigen receptor T (CAR-T) cells market size is expected to grow to $10.24 billion in 2027 at a CAGR of 38.8%.

The increasing occurrences of cancer is driving the chimeric antigen receptor T (CAR-T) cells market. Cancer is a chronic disease in which normal body cells divide and grow without any control and affect the nearest body tissue and turn into tumor cells. The chimeric antigen receptor T (CAR-T) cells are used to treat various types of cancers such as haematological malignancies, including acute lymphoblastic leukemia and chronic lymphocytic leukemia, and can also treat solid tumors such as breast cancer and sarcoma. For instance, in 2021, according to the American Cancer Society, a voluntary health organization, global cancer patients diagnosed is expected to reach 1.9 million in 2021. Due to population growth and ageing, the worldwide burden of cancer is predicted to reach 27.5 million new cases and 16.2 million cancer deaths by 2040. Therefore, the rising prevalence of cancer is anticipated to boost the chimeric antigen receptor T (CAR-T) cells market in the upcoming years.

Product innovation is a key trend gaining popularity in the chimeric antigen receptor T (CAR-T) cells market. Major market players operating in the chimeric antigen receptor T (CAR-T) cells market are concentrating their efforts on creating innovative technologies to develop novel CAR-T cell-based treatments. For instance, in December 2021, Novartis AG, a Switzerland-based pharmaceutical company specializing in the development and manufacturing of drugs, launched the T-Charge CAR-T platform. This technology-enabled platform enables the body to renew and mature CAR-T cells, offering a greater proliferative environment for cells.

In November 2021, Laurus Labs, an India-based pharmaceutical and biotechnology company, acquired a substantial minority stake (26.62%) in Immunoadoptive Cell Therapy (ImmunoACT) for $5.56 million (INR 0.46 billion). With this acquisition, Laurus Labs will strengthen its biologics business and gain access to an emerging field of research. Immunoadoptive Cell Therapy is an India-based CAR-T cell-therapy company.

Major players in the chimeric antigen receptor t (CAR-T) cells market are Novartis International AG, Pfizer Inc., Gilead Sciences Inc., Autolus Therapeutics Plc, CARsgen Therapeutics Company Limited, Bristol-Myers Squibb Company, Sorrento Therapeutics Inc., Legend Biotech, Mustang Bio Inc., Bluebird Bio Inc., and Eureka Therapeutics Inc.

North America was the largest region in the chimeric antigen receptor T (CAR-T) cells market in 2022. The regions covered in the chimeric antigen receptor T (CAR-T) cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the chimeric antigen receptor T (CAR-T) cells market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA.

The chimeric antigen receptor T (CAR-T) cells market includes revenues earned by entities by providing chimeric antigen receptor T (CAR-T) cells that are used to cure blood cancers. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The global chimeric antigen receptor t (CAR-T) cells market is segmented -

1) By Target Antigen: CD19, CD22, Other Antigens

2) By Application: Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Other Applications

3) By End User: Hospitals, Cancer Research Centres, Clinics

    Table Of Contents

    1. Executive Summary

    2. Chimeric Antigen Receptor T (CAR-T) Cells Market Characteristics

    3. Chimeric Antigen Receptor T (CAR-T) Cells Market Trends And Strategies

    4. Chimeric Antigen Receptor T (CAR-T) Cells Market - Macro Economic Scenario

    4.1. COVID-19 Impact On Chimeric Antigen Receptor T (CAR-T) Cells Market

    4.2. Ukraine-Russia War Impact On Chimeric Antigen Receptor T (CAR-T) Cells Market

    4.3. Impact Of High Inflation On Chimeric Antigen Receptor T (CAR-T) Cells Market

    5. Chimeric Antigen Receptor T (CAR-T) Cells Market Size And Growth

    5.1. Global Chimeric Antigen Receptor T (CAR-T) Cells Historic Market, 2017-2022, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Chimeric Antigen Receptor T (CAR-T) Cells Forecast Market, 2022-2027F, 2032F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Chimeric Antigen Receptor T (CAR-T) Cells Market Segmentation

    6.1. Global Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    CD19

    CD22

    Other Antigens

    6.2. Global Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Acute Lymphoblastic Leukaemia

    Diffuse Large B-Cell Lymphoma

    Other Applications

    6.3. Global Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Hospitals

    Cancer Research Centres

    Clinics

    7. Chimeric Antigen Receptor T (CAR-T) Cells Market Regional And Country Analysis

    7.1. Global Chimeric Antigen Receptor T (CAR-T) Cells Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    7.2. Global Chimeric Antigen Receptor T (CAR-T) Cells Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8. Asia-Pacific Chimeric Antigen Receptor T (CAR-T) Cells Market

    8.1. Asia-Pacific Chimeric Antigen Receptor T (CAR-T) Cells Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8.3. Asia-Pacific Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    9. China Chimeric Antigen Receptor T (CAR-T) Cells Market

    9.1. China Chimeric Antigen Receptor T (CAR-T) Cells Market Overview

    9.2. China Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    9.3. China Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    10. India Chimeric Antigen Receptor T (CAR-T) Cells Market

    10.1. India Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    10.2. India Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11. Japan Chimeric Antigen Receptor T (CAR-T) Cells Market

    11.1. Japan Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11.2. Japan Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12. Australia Chimeric Antigen Receptor T (CAR-T) Cells Market

    12.1. Australia Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12.2. Australia Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13. Indonesia Chimeric Antigen Receptor T (CAR-T) Cells Market

    13.1. Indonesia Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13.2. Indonesia Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14. South Korea Chimeric Antigen Receptor T (CAR-T) Cells Market

    14.1. South Korea Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14.2. South Korea Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15. Western Europe Chimeric Antigen Receptor T (CAR-T) Cells Market

    15.1. Western Europe Chimeric Antigen Receptor T (CAR-T) Cells Market Overview

    15.2. Western Europe Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15.3. Western Europe Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16. UK Chimeric Antigen Receptor T (CAR-T) Cells Market

    16.1. UK Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16.2. UK Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17. Germany Chimeric Antigen Receptor T (CAR-T) Cells Market

    17.1. Germany Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17.2. Germany Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18. France Chimeric Antigen Receptor T (CAR-T) Cells Market

    18.4. France Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18.5. France Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19. Eastern Europe Chimeric Antigen Receptor T (CAR-T) Cells Market

    19.1. Eastern Europe Chimeric Antigen Receptor T (CAR-T) Cells Market Overview

    19.2. Eastern Europe Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19.3. Eastern Europe Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20. Russia Chimeric Antigen Receptor T (CAR-T) Cells Market

    20.1. Russia Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20.2. Russia Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21. North America Chimeric Antigen Receptor T (CAR-T) Cells Market

    21.1. North America Chimeric Antigen Receptor T (CAR-T) Cells Market Overview

    21.2. North America Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21.3. North America Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22. USA Chimeric Antigen Receptor T (CAR-T) Cells Market

    22.1. USA Chimeric Antigen Receptor T (CAR-T) Cells Market Overview

    22.2. USA Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22.3. USA Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23. South America Chimeric Antigen Receptor T (CAR-T) Cells Market

    23.1. South America Chimeric Antigen Receptor T (CAR-T) Cells Market Overview

    23.2. South America Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23.3. South America Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24. Brazil Chimeric Antigen Receptor T (CAR-T) Cells Market

    24.1. Brazil Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24.2. Brazil Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25. Middle East Chimeric Antigen Receptor T (CAR-T) Cells Market

    25.1. Middle East Chimeric Antigen Receptor T (CAR-T) Cells Market Overview

    25.2. Middle East Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25.3. Middle East Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26. Africa Chimeric Antigen Receptor T (CAR-T) Cells Market

    26.1. Africa Chimeric Antigen Receptor T (CAR-T) Cells Market Overview

    26.2. Africa Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26.3. Africa Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    27. Chimeric Antigen Receptor T (CAR-T) Cells Market Competitive Landscape And Company Profiles

    27.1. Chimeric Antigen Receptor T (CAR-T) Cells Market Competitive Landscape

    27.2. Chimeric Antigen Receptor T (CAR-T) Cells Market Company Profiles

    27.2.1. Novartis International AG

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Pfizer Inc

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Gilead Sciences Inc

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Autolus Therapeutics Plc

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. CARsgen Therapeutics Company Limited

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Chimeric Antigen Receptor T (CAR-T) Cells Market

    29. Chimeric Antigen Receptor T (CAR-T) Cells Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Historic And Forecast Inflation Rates

    30.4. Research Inquiries

    30.5. The Business Research Company

    30.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Table 3: Global Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 4: Global Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 5: Global Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 6: Global Chimeric Antigen Receptor T (CAR-T) Cells Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 7: Global Chimeric Antigen Receptor T (CAR-T) Cells Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 8: Asia-Pacific, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 9: Asia-Pacific, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 10: China, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 11: China, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 12: India, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 13: India, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 14: Japan, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 15: Japan, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 16: Australia, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 17: Australia, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 18: Indonesia, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 19: Indonesia, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 20: South Korea, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 21: South Korea, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 22: Western Europe, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 23: Western Europe, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 24: UK, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 25: UK, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 26: Germany, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 27: Germany, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 28: France, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 29: France, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 30: Eastern Europe, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 31: Eastern Europe, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 32: Russia, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 33: Russia, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 34: North America, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 35: North America, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 36: USA, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 37: USA, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 38: South America, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 39: South America, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 40: Brazil, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 41: Brazil, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 42: Middle East, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 43: Middle East, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 44: Africa, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 45: Africa, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 46: Novartis International AG Financial Performance
  • Table 47: Pfizer Inc Financial Performance
  • Table 48: Gilead Sciences Inc Financial Performance
  • Table 49: Autolus Therapeutics Plc Financial Performance
  • Table 50: CARsgen Therapeutics Company Limited Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Figure 3: Global Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 4: Global Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 5: Global Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 6: Global Chimeric Antigen Receptor T (CAR-T) Cells Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 7: Global Chimeric Antigen Receptor T (CAR-T) Cells Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 8: Asia-Pacific, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 9: Asia-Pacific, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 10: China, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 11: China, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 12: India, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 13: India, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 14: Japan, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 15: Japan, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 16: Australia, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 17: Australia, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 18: Indonesia, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 19: Indonesia, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 20: South Korea, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 21: South Korea, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 22: Western Europe, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 23: Western Europe, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 24: UK, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 25: UK, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 26: Germany, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 27: Germany, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 28: France, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 29: France, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 30: Eastern Europe, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 31: Eastern Europe, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 32: Russia, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 33: Russia, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 34: North America, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 35: North America, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 36: USA, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 37: USA, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 38: South America, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 39: South America, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 40: Brazil, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 41: Brazil, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 42: Middle East, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 43: Middle East, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 44: Africa, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 45: Africa, Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 46: Novartis International AG Financial Performance
  • Figure 47: Pfizer Inc Financial Performance
  • Figure 48: Gilead Sciences Inc Financial Performance
  • Figure 49: Autolus Therapeutics Plc Financial Performance
  • Figure 50: CARsgen Therapeutics Company Limited Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report